DBV Technologies (DBVT) Total Liabilities (2015 - 2026)
DBV Technologies (DBVT) reported Total Liabilities of $58.4 million for Q1 2026, up 22.46% year-over-year from $47.7 million in Q1 2025, and down 10.02% quarter-over-quarter from $64.9 million in Q4 2025.
DBV Technologies (DBVT) Total Liabilities (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 12 years of Total Liabilities data on file, last reported at $58.4 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $58.4 million, up 22.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.4 million (up 22.46% YoY), and the FY2025 annual result was $64.9 million, up 69.58% from the prior year.
- Total Liabilities retreated to $58.4 million in Q1 2026 per DBVT's latest filing, from $64.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $64.9 million in Q4 2025 and troughed at $34.2 million in Q1 2024.
- A 5-year average of $46.6 million and a median of $45.8 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities plunged 36.4% in 2024, then soared 69.58% in 2025.
- A 5-year view of Total Liabilities shows it stood at $52.1 million in 2022, then slipped by 17.8% to $42.8 million in 2023, then retreated by 10.58% to $38.3 million in 2024, then surged by 69.58% to $64.9 million in 2025, then slipped by 10.02% to $58.4 million in 2026.
- Business Quant data shows DBVT's Total Liabilities at $58.4 million in Q1 2026, $64.9 million in Q4 2025, and $57.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 58.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.40 Mn |
| Dec 31, 2025 | 64.90 Mn |
| Sep 30, 2025 | 57.64 Mn |
| Jun 30, 2025 | 57.21 Mn |
| Mar 31, 2025 | 47.69 Mn |
| Dec 31, 2024 | 38.27 Mn |
| Sep 30, 2024 | 39.02 Mn |
| Jun 30, 2024 | 35.10 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Dec 31, 2023 | 42.80 Mn |
| Sep 30, 2023 | 45.79 Mn |
| Jun 30, 2023 | 53.28 Mn |
| Mar 31, 2023 | 53.83 Mn |
| Dec 31, 2022 | 52.06 Mn |
| Sep 30, 2022 | 36.07 Mn |
| Jun 30, 2022 | 40.56 Mn |
| Mar 31, 2022 | 35.52 Mn |
| Dec 31, 2021 | 47.45 Mn |
| Sep 30, 2021 | 54.03 Mn |
| Jun 30, 2021 | 57.57 Mn |